These findings align closely with prior cardiovascular outcome trials and solidify the evidence base by demonstrating consistent benefits in broader patient populations treated in clinical practice
"Registered dietitians are exceptional sources of knowledge when it comes to supporting people on their GLP-1 journey to address any nutrition challenges and incorporate the food and benefits they need into their daily lives," Whitney Evans, PhD, RD and director, nutrition & scientific affairs, Danone North America, said in the release
(20) In contrast, Hansen et al
An Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk In a new analysis, KFF finds that 3.6 million people with Medicare could be eligible for coverage of Wegovy (semaglutide) now that the Food and Drug Administration has approved the use of the anti-obesity drug to reduce the risk of heart attacks and stroke in certain patients
The FDA is investigating these reports, though a causal relationship has not been definitively established
It functions as a donor of methyl groups for healthy methylation in over 100 different reactions in the body